Seminars in Cancer Biology

Papers
(The H4-Index of Seminars in Cancer Biology is 79. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Editorial Board412
Editorial Board364
Dissecting the heritable risk of breast cancer: From statistical methods to susceptibility genes286
Small secretory proteins of immune cells can modulate gynecological cancers257
Advances in biology and novel treatments of SCLC232
Breast cancer metastasis to bone: From epithelial to mesenchymal transition to breast osteoblast-like cells224
Targeting Hippo signaling pathway by phytochemicals in cancer therapy204
Emerging applications of bacteria as antitumor agents197
Unveiling the role of PIK3R1 in cancer: A comprehensive review of regulatory signaling and therapeutic implications195
Deregulated transcription factors in the emerging cancer hallmarks190
The molecular chaperone TRAP1 in cancer: From the basics of biology to pharmacological targeting185
Critical DNA damaging pathways in tumorigenesis183
Carbonic anhydrase IX: A tumor acidification switch in heterogeneity and chemokine regulation182
Biology of cancer; from cellular and molecular mechanisms to developmental processes and adaptation180
Updated review on green tea polyphenol epigallocatechin-3-gallate as a cancer epigenetic regulator177
Multifaceted role of chemokines in solid tumors: From biology to therapy169
Editorial Board168
Special issue: Deregulated transcription factors in the cancer therapeutic challenges: An update on cancer stemness features165
Editorial Board161
Gut microbes in gastrointestinal cancers156
Extracellular vesicles associated microRNAs: Their biology and clinical significance as biomarkers in gastrointestinal cancers156
Association of Chlamydia and Mycoplasma infections with susceptibility to ovarian cancer: A systematic review and meta-analysis155
Erratum to “RNA regulatory mechanisms controlling TGF-β signaling and EMT in cancer” [Semin. Cancer Biol. 102–103 (2024) 4–16]150
Genomic profiling of sporadic liver metastatic colorectal cancer148
Targeting micro-environmental pathways by PROTACs as a therapeutic strategy141
Multifaceted functions of chronic inflammation in regulating tumor dormancy and relapse139
Excess body weight and postmenopausal breast cancer: Emerging molecular mechanisms and perspectives139
PIWI-interacting RNAs in human cancer134
Innovative trial design in precision oncology133
Thinking small to win big? A critical review on the potential application of extracellular vesicles for biomarker discovery and new therapeutic approaches in pancreatic cancer130
Molecular targets of tyrosine kinase inhibitors in thyroid cancer126
Microbiome dysbiosis and epigenetic modulations in lung cancer: From pathogenesis to therapy120
Targeting monocarboxylate transporters (MCTs) in cancer: How close are we to the clinics?119
Origins and molecular effects of hypoxia in cancer117
The IL-1 family in tumorigenesis and antitumor immunity117
Immune cellular components and signaling pathways in the tumor microenvironment116
Anticancer properties of chimeric HDAC and kinase inhibitors116
Genome chaos: Creating new genomic information essential for cancer macroevolution114
Enhancing head and neck tumor management with artificial intelligence: Integration and perspectives111
New biological and immunological approaches to cancer therapy: Basic and clinical aspects111
Targeting the “undruggable”: RNA-binding proteins in the spotlight in cancer therapy110
Modulation of the tumor microenvironment by natural agents: implications for cancer prevention and therapy108
Reprogramming of glycolysis by chemical carcinogens during tumor development108
Extracellular vesicles in glioblastoma: Biomarkers and therapeutic tools104
Cellular stress responses and metabolic reprogramming in cancer progression and dormancy104
Multi-omic markers of intraductal papillary mucinous neoplasms progression into pancreatic cancer103
Therapy-induced modulation of extracellular vesicles in hepatocellular carcinoma103
Anticancer natural products targeting immune checkpoint protein network101
Unravelling the complexities of resistance mechanism in pancreatic cancer: Insights from in vitro and ex-vivo model systems100
Editorial Board100
Metabolic landscape and rewiring in normal hematopoiesis, leukemia and aging99
Atrial fibrillation in cancer patients: Epidemiology, identification and management98
Insight into the role of multiple signaling pathways in regulating cancer stem cells of gynecologic cancers97
Regulation of the aryl hydrocarbon receptor in cancer and cancer stem cells of gynecological malignancies: An update on signaling pathways97
The intricacies of NRF2 regulation in cancer96
Regulation of epithelial-mesenchymal transition by tumor microenvironmental signals and its implication in cancer therapeutics96
Advancement of cancer immunotherapy using nanoparticles-based nanomedicine96
Curcumin and colorectal cancer: An update and current perspective on this natural medicine95
How far have we explored fungi to fight cancer?95
Integrative microphysiological tissue systems of cancer metastasis to the liver95
Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer94
Vibrational spectroscopy for decoding cancer microbiota interactions: Current evidence and future perspective94
Role of LDH in tumor glycolysis: Regulation of LDHA by small molecules for cancer therapeutics94
Cancer cell heterogeneity & plasticity in glioblastoma and brain tumors90
Editorial Board89
Editorial Board88
The role of RNA processing and regulation in metastatic dormancy88
Prostate cancer liver metastasis: Dormancy and resistance to therapy88
Cytotoxic activity of l-lysine alpha-oxidase against leukemia cells88
Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applications87
Drivers of centrosome abnormalities: Senescence progression and tumor immune escape87
Emerging perspectives on growth factor metabolic relationships in the ovarian cancer ascites environment86
Transcription networks rewire gene repertoire to coordinate cellular reprograming in prostate cancer85
The foundational framework of tumors: Gametogenesis, p53, and cancer84
Role of ubiquitination-driven metabolisms in oncogenesis and cancer therapy84
MITOCHONDRIAL CHOLESTEROL AND CANCER83
Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer82
The role of tumor microenvironment and exosomes in dormancy and relapse80
Clinical utility of whole-genome sequencing in precision oncology80
0.13655185699463